FDA recalls another CareFusion infusion pump
(Reuters) - U.S. health regulators announced a recall of CareFusion's Alaris pump module Model 8100, saying a potential keypad malfunction in the infusion pump could cause serious injury or death.
The U.S. Food and Drug Administration said the affected pump modules, used for delivering a variety of fluids, drugs and blood products to patients, were manufactured between October 2011 and February 2012.
The FDA classified the action as a Class I recall on its website, meaning that the defective units could cause serious harm to a patient's health.
Earlier this month, the FDA had announced a Class I recall of another CareFusion pump, the Alaris PC unit Model 8015, citing a malfunction in its power supply board.
Shares of CareFusion closed at $26.61 on the New York Stock Exchange on Wednesday.
(Reporting by Balaji Sridharan in Bangalore; Editing by Anthony Kurian)
- Israel pummels Gaza; Kerry steps up diplomatic push |
- With sales sputtering, Apple's iPad looks to IBM alliance
- Ukraine war crimes trials a step closer after Red Cross assessment
- Five held in China food scandal probe, including head of Shanghai Husi Food
- Rebels likely downed Malaysian jet 'by mistake': U.S. officials
Robert Blendon of the Harvard School of Public Health says the Affordable Care Act's unpopularity in 12 key states will keep it a central issue in the 2014 elections. Video